ArticleFrontiers in epidemiology2024
A systematic analysis of the global, regional, and national burden of fungal skin diseases from 1990 to 2021.
Article in Frontiers in epidemiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Resistance and Recalcitrance in Dermatophytosis: Mechanistic and Clinical Considerations for Keratinized Tissues.Antibiotics (Basel, Switzerland) · 2026Review
- Burden of non-invasive fungal infections and antifungal therapy in pediatric primary care settings: FUNGICARE Project.Italian journal of pediatrics · 2026Article
- Superficial Fungal Infection Associations with Comorbid Diseases and Risk Factors: An Analysis of Global Burden of Disease 2023.Infectious disease reports · 2026Article
- Integrating Machine Learning and Molecular Methods forPathogens (Basel, Switzerland) · 2025Article
- An Updated Perspective on Skin Disease Therapy: From Conventional Methods to Nanocarrier Innovations.AAPS PharmSciTech · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: We aimed to assess the burden of Fungal Skin Diseases (FSD) in 2021 and explore the changing trends from 1990 to 2021 across different age groups and time periods. Methods: This study extracted three key indicators of the burden of FSD from the Global Burden of Disease (GBD) 2021 study: prevalence, incidence, and disability-adjusted life years (DALYs). The results were presented using point estimates and Uncertainty Intervals (UIs), and secondary analysis was conducted on these data to assess the changing trends in the burden of FSD using percentage change. Results: In 2021, the global cases of prevalence, incidence, and DALYs of FSD were reported at 616.5 million, 1,729.2 million, and 3,429.5 thousand, respectively, an increase of approximately 68% since 1990. The age-standardized rates per 100,000 population for prevalence, incidence, and DALYs were 7,789.6, 21,668.4, and 43.4, respectively. These rates represent percentage increases of 6.21%, 3.74%, and 6.56% since 1990. In terms of age distribution, the ages for FSD-related prevalence, incidence, and DALYs peak cases globally were in the 5-9 age group, with distinct age groups observed in low and low-middle, middle, high-middle and high SDI regions at 5-9 years, 45-49 years, and 70-74 years, respectively. Conclusion: Over the past 32 years, there has been a significant increase in the global burden of FSD. With improvements in the Socio-Demographic Index (SDI), the age groups for FSD-related peak cases are gradually shifting towards older age groups. This indicates the need to allocate healthcare resources rationally to address the challenges arising from the significant differences in geographic distribution, gender, and among different populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.